-
-

 
-
News
June 4 2021
Preclinapps is carrying out a research program to investigate 3D printing of drug deliv...

-


PRICE QUOTE AND TECHNICAL INQUIRIES

Request Information


FOLLOW US

PreclinApps Ltd is a medical technology company focused on developing and commercializing products for preclinical drug discovery markets

Company´s key products are polymer based long-term delivery systems called MedRod®, designed for preclinical animal research. PreclinApps can also serve as a contract research organization (CRO) and provide services for pharmaceutical industry and other research facilities.

The company was founded in 2014 by co-founders. Our mission is to develop novel sustained release systems that are scientifically better, cost-efficient, more ethical for animals and have better compliance for patients. To achieve this goal we have sustained release technology platforms that enable stable release of small to macromolecules from days to several years. Preclinapps has research facilities at the Smart Chemistry Park (SCP) in Raisio, Southwest Finland. SCP is an innovation platform for bio- and circular economies which core competence lies in different fields of chemistry. See SCP video

-
Preclinapps research facilities at Smart Chemistry Park.
-
About Us
 
-
 Management
-
 History
-
Implants for Research
 
-
 E2 estradiol
-
 DHT
-
 Progesterone
-
Drug Delivery Solutions
 
-
 Feasibility study of novel compound
-
Services
 
References
 
-
 MedRod brochure
-
Contact Us
 
Benefits of MedRod®
 
103434  | Copyright © 2021 PreclinApps Ltd   
Web dev. Webbinen.net